{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:23:10Z","timestamp":1789201390315,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,4,11]],"date-time":"2016-04-11T00:00:00Z","timestamp":1460332800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Regulatory Science of Pharmaceuticals and Medical Devices from the Ministry of Health, Labour and Welfare, Japan","award":["15Emk0101001h0015"],"award-info":[{"award-number":["15Emk0101001h0015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00213-016-4282-1","type":"journal-article","created":{"date-parts":[[2016,4,11]],"date-time":"2016-04-11T05:13:27Z","timestamp":1460351607000},"page":"2343-2353","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Narcolepsy-like sleep disturbance in orexin knockout mice are normalized by the 5-HT1A receptor agonist 8-OH-DPAT"],"prefix":"10.1007","volume":"233","author":[{"given":"Tomohisa","family":"Mori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Uzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Iwase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Masukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahardian","family":"Rahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeto","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuna","family":"Hokazono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimio","family":"Higashiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Shioda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,11]]},"reference":[{"key":"4282_CR1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.smrv.2004.03.002","volume":"8","author":"D Banerjee","year":"2004","unstructured":"Banerjee D, Vitiello MV, Grunstein RR (2004) Pharmacotherapy for excessive daytime sleepiness. Sleep Med Rev 8:339\u2013354","journal-title":"Sleep Med Rev"},{"key":"4282_CR2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0092-8674(00)81973-X","volume":"98","author":"RM Chemelli","year":"1999","unstructured":"Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, Fitch TE, Nakazato M, Hammer RE, Saper CB, Yanagisawa M (1999) Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98:437\u2013451","journal-title":"Cell"},{"key":"4282_CR3","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1073\/pnas.96.2.748","volume":"96","author":"Y Date","year":"1999","unstructured":"Date Y, Ueta Y, Yamashita H, Yamaguchi H, Matsukura S, Kangawa K, Sakurai T, Yanagisawa M, Nakazato M (1999) Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc Natl Acad Sci U S A 96:748\u2013753","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4282_CR4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2869.1992.tb00032.x","volume":"1","author":"C Dugovic","year":"1992","unstructured":"Dugovic C (1992) Functional activity of 5-HT2 receptors in the modulation of the sleep\/wakefulness states. J Sleep Res 1:163\u2013168","journal-title":"J Sleep Res"},{"key":"4282_CR5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0306-4522(02)00017-9","volume":"111","author":"J Fadel","year":"2002","unstructured":"Fadel J, Deutch AY (2002) Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area. Neuroscience 111:379\u2013387","journal-title":"Neuroscience"},{"key":"4282_CR6","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.pbb.2007.09.007","volume":"88","author":"WE Fantegrossi","year":"2008","unstructured":"Fantegrossi WE, Reissig CJ, Katz EB, Yarosh HL, Rice KC, Winter JC (2008) Hallucinogen-like effects of N, N-dipropyltryptamine (DPT): possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents. Pharmacol Biochem Behav 88:358\u2013365","journal-title":"Pharmacol Biochem Behav"},{"key":"4282_CR7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/pr.55.3.3","volume":"55","author":"AR Green","year":"2003","unstructured":"Green AR, Mechan AO, Elliott JM, O\u2019Shea E, Colado MI (2003) The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d). Pharmacol Rev 55:463\u2013508","journal-title":"Pharmacol Rev"},{"key":"4282_CR8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0896-6273(01)00293-8","volume":"30","author":"J Hara","year":"2001","unstructured":"Hara J, Beuckmann CT, Nambu T, Willie JT, Chemelli RM, Sinton CM, Sugiyama F, Yagami K, Goto K, Yanagisawa M, Sakurai T (2001) Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 30:345\u2013354","journal-title":"Neuron"},{"key":"4282_CR9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0031-6997(25)06783-3","volume":"46","author":"D Hoyer","year":"1994","unstructured":"Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157\u2013203","journal-title":"Pharmacol Rev"},{"key":"4282_CR10","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.pbb.2004.05.008","volume":"78","author":"MS Hunsley","year":"2004","unstructured":"Hunsley MS, Palmiter RD (2004) Altered sleep latency and arousal regulation in mice lacking norepinephrine. Pharmacol Biochem Behav 78:765\u2013773","journal-title":"Pharmacol Biochem Behav"},{"key":"4282_CR11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1756-6606-6-59","volume":"6","author":"H Ito","year":"2013","unstructured":"Ito H, Yanase M, Yamashita A, Kitabatake C, Hamada A, Suhara Y, Narita M, Ikegami D, Sakai H, Yamazaki M, Narita M (2013) Analysis of sleep disorders under pain using an optogenetic tool: possible involvement of the activation of dorsal raphe nucleus-serotonergic neurons. Mol Brain 6:59","journal-title":"Mol Brain"},{"key":"4282_CR12","first-page":"134","volume-title":"Principles and practice of sleep medicine","author":"BE Jones","year":"2000","unstructured":"Jones BE (2000) Basic mechanisms of sleep-wake states. In: Kryger MH, Roth T, Dement WC (eds) Principles and practice of sleep medicine. Saunders, Philadelphia, pp 134\u2013154"},{"key":"4282_CR13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1212\/WNL.42.1.229","volume":"42","author":"SJ Kish","year":"1992","unstructured":"Kish SJ, Mamelak M, Slimovitch C, Dixon LM, Lewis A, Shannak K, DiStefano L, Chang LJ, Hornykiewicz O (1992) Brain neurotransmitter changes in human narcolepsy. Neurology 42:229\u2013234","journal-title":"Neurology"},{"key":"4282_CR14","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0022-3565(24)38829-9","volume":"296","author":"R Kuczenski","year":"2001","unstructured":"Kuczenski R, Segal DS (2001) Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine. J Pharmacol Exp Ther 296:876\u2013883","journal-title":"J Pharmacol Exp Ther"},{"key":"4282_CR15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00213-002-1141-z","volume":"164","author":"D Marona-Lewicka","year":"2002","unstructured":"Marona-Lewicka D, Kurrasch-Orbaugh DM, Selken JR, Cumbay MG, Lisnicchia JG, Nichols DE (2002) Re-evaluation of lisuride pharmacology: 5-hydroxytryptamine1A receptor-mediated behavioral effects overlap its other properties in rats. Psychopharmacology 164:93\u2013107","journal-title":"Psychopharmacology"},{"key":"4282_CR16","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0899-9007(00)00449-4","volume":"16","author":"MM Meguid","year":"2000","unstructured":"Meguid MM, Fetissov SO, Varma M, Sato T, Zhang L, Laviano A, Rossi-Fanelli F (2000) Hypothalamic dopamine and serotonin in the regulation of food intake. Nutrition 16:843\u2013857","journal-title":"Nutrition"},{"key":"4282_CR17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2869.1992.tb00033.x","volume":"1","author":"JM Monti","year":"1992","unstructured":"Monti JM, Jantos H (1992) Dose-dependent effects of the 5-HT1A receptor agonist 8-OH-DPAT on sleep and wakefulness in the rat. J Sleep Res 1:169\u2013175","journal-title":"J Sleep Res"},{"key":"4282_CR18","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.neuropharm.2009.08.009","volume":"58","author":"T Mori","year":"2010","unstructured":"Mori T, Ito S, Kuwaki T, Yanagisawa M, Sakurai T, Sawaguchi T (2010) Monoaminergic neuronal changes in orexin deficient mice. Neuropharmacology 58:826\u2013832","journal-title":"Neuropharmacology"},{"key":"4282_CR19","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1124\/jpet.114.214288","volume":"350","author":"T Mori","year":"2013","unstructured":"Mori T, Uzawa N, Kazawa H, Watanabe H, Mochizuki A, Shibasaki M, Yoshizawa K, Suzuki T (2013) Differential substitution for the discriminative stimulus effects of 3,4-methylenedioxymethamphetamine and methylphenidate in rats. J Pharmacol Exp Ther 350:403\u2013411","journal-title":"J Pharmacol Exp Ther"},{"key":"4282_CR20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0006-8993(00)02555-5","volume":"873","author":"T Nakamura","year":"2000","unstructured":"Nakamura T, Uramura K, Nambu T, Yada T, Goto K, Yanagisawa M, Sakurai T (2000) Orexin-induced hyperlocomotion and stereotypy are mediated by the dopaminergic system. Brain Res 873:181\u2013187","journal-title":"Brain Res"},{"key":"4282_CR21","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1523\/JNEUROSCI.21-11-03715.2001","volume":"21","author":"M Narita","year":"2001","unstructured":"Narita M, Mizoguchi H, Narita M, Nagase H, Suzuki T, Tseng LF (2001) Involvement of spinal protein kinase Cgamma in the attenuation of opioid mu-receptor-mediated G-protein activation after chronic intrathecal administration of [D-Ala2, N-MePhe4, Gly-Ol(5)]enkephalin. J Neurosci 21:3715\u20133720","journal-title":"J Neurosci"},{"key":"4282_CR22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","volume":"355","author":"S Nishino","year":"2000","unstructured":"Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E (2000) Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355:39\u201340","journal-title":"Lancet"},{"key":"4282_CR23","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1471-4159.2008.05632.x","volume":"107","author":"SA Perrine","year":"2008","unstructured":"Perrine SA, Miller JS (2008) Cocaine regulates protein kinsase B and glycogen synthase kinase-3 activity in selective regions of rat brain. J Neurochem 107:570\u2013577","journal-title":"J Neurochem"},{"key":"4282_CR24","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","volume":"18","author":"C Peyron","year":"1998","unstructured":"Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, Kilduff TS (1998) Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18:9996\u201310015","journal-title":"J Neurosci"},{"key":"4282_CR25","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/79690","volume":"6","author":"C Peyron","year":"2000","unstructured":"Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, Nevsimalova S, Aldrich M, Reynolds D, Albin R, Li R, Hungs M, Pedrazzoli M, Padigaru M, Kucherlapati M, Fan J, Maki R, Lammers GJ, Bouras C, Kucherlapati R, Nishino S, Mignot E (2000) A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6:991\u2013997","journal-title":"Nat Med"},{"key":"4282_CR26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.cellsig.2011.09.009","volume":"24","author":"AM Polter","year":"2012","unstructured":"Polter AM, Yang S, Jope RS, Li X (2012) Functional significance of glycogen synthase kinase-3 regulation by serotonin. Cell Signal 24:265\u2013271","journal-title":"Cell Signal"},{"key":"4282_CR27","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/syn.20893","volume":"65","author":"M Rahmadi","year":"2011","unstructured":"Rahmadi M, Narita M, Yamashita A, Imai S, Kuzumaki N, Suzuki T (2011) Sleep disturbance associated with an enhanced orexinergic system induced by chronic treatment with paroxetine and milnacipran. Synapse 65:652\u2013657","journal-title":"Synapse"},{"key":"4282_CR28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/sleep\/32.2.133","volume":"32","author":"TE Scammell","year":"2009","unstructured":"Scammell TE, Willie JT, Guilleminault C, Siegel JM (2009) A consensus definition of cataplexy in mouse models of narcolepsy. Sleep 32:111\u2013116","journal-title":"Sleep"},{"key":"4282_CR29","first-page":"112","volume-title":"Principles and practice of sleep medicine, Saunders Philadelphia","author":"JM Siegel","year":"2000","unstructured":"Siegel JM (2000) Brainstem mechanisms generating REM sleep. In: Kryger MH, Roth T, Dement WC (eds) Principles and practice of sleep medicine, Saunders Philadelphia. Saunders, Philadelphia, pp 112\u2013133"},{"key":"4282_CR30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejphar.2007.06.062","volume":"574","author":"T Suzuki","year":"2007","unstructured":"Suzuki T, Shindo K, Miyatake M, Kurokawa K, Higashiyama K, Suzuki M, Narita M (2007) Lack of development of behavioral sensitization to methylphenidate in mice: correlation with reversible astrocytic activation. Eur J Pharmacol 574:39\u201348","journal-title":"Eur J Pharmacol"},{"key":"4282_CR31","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0896-6273(00)00058-1","volume":"27","author":"TC Thannickal","year":"2000","unstructured":"Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, Cornford M, Siegel JM (2000) Reduced number of hypocretin neurons in human narcolepsy. Neuron 27:469\u2013474","journal-title":"Neuron"},{"key":"4282_CR32","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.sleep.2007.03.004","volume":"8","author":"M Thorpy","year":"2007","unstructured":"Thorpy M (2007) Therapeutic advances in narcolepsy. Sleep Med 8:427\u2013440","journal-title":"Sleep Med"},{"key":"4282_CR33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.sleep.2014.10.002","volume":"16","author":"MJ Thorpy","year":"2015","unstructured":"Thorpy MJ, Dauvilliers Y (2015) Clinical and practical considerations in the pharmacologic management of narcolepsy. Sleep Med 16:9\u201318","journal-title":"Sleep Med"},{"key":"4282_CR34","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0896-6273(03)00330-1","volume":"38","author":"JT Willie","year":"2003","unstructured":"Willie JT, Chemelli RM, Sinton CM, Tokita S, Williams SC, Kisanuki YY, Marcus JN, Lee C, Elmquist JK, Kohlmeier KA, Leonard CS, Richardson JA, Hammer RE, Yanagisawa M (2003) Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes. Neuron 38:715\u2013730","journal-title":"Neuron"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-016-4282-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-016-4282-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-016-4282-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T11:16:57Z","timestamp":1748863017000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-016-4282-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,11]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["4282"],"URL":"https:\/\/doi.org\/10.1007\/s00213-016-4282-1","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,11]]}}}